Sign In

Gregg Peterson

CEO at Bexson Biomedical

Gregg Peterson is the Chief Executive Officer (CEO) of Bexson Biomedical, an innovative pharmaceutical company specializing in non-opioid therapies for pain management and mental health.

With a remarkable career spanning over two decades, Gregg boasts extensive experience in the development of pharmaceuticals, medical devices, biologics, and combination products, having overseen the successful commercial launch of more than a dozen products worldwide.

Prior to his role at Bexson Biomedical, Gregg served as the Global Research and Development (R&D) Program Lead for a prominent S&P500 company, focusing on regions such as the United States, European Union, and Asia Pacific.

His proven track record includes managing R&D programs across various stages, starting from market research and concept development to overseeing Phase I-III clinical trials and obtaining regulatory approvals.

Gregg's entrepreneurial spirit is evident through his involvement with multiple startup ventures, several of which have culminated in successful outcomes, including the IPOs of Evolus and Somaxon, as well as the acquisition of TargeGen by Sanofi-Aventis.

In terms of education, Gregg pursued a Master of Arts (MA) degree at the Medical College of Wisconsin and completed his Bachelor of Science (BS) studies at the University of Puget Sound.

Apart from his role as CEO at Bexson Biomedical, Gregg has held various key positions in reputable organizations such as Spaulding Clinical Research, LLC, Beartooth Biotech, Evolus, Allergan Medical, TargeGen, Inc., Somaxon Pharmaceuticals, and PPD.

Gregg Peterson's vast experience, leadership in research and development, and entrepreneurial acumen make him a distinguished figure in the pharmaceutical industry.

Gregg Peterson
Add to my network

Location

Santa Barbara, California